首页> 外文期刊>BMC Medical Informatics and Decision Making >Traditional Chinese medicine pharmacovigilance in signal detection: decision tree-based data classification
【24h】

Traditional Chinese medicine pharmacovigilance in signal detection: decision tree-based data classification

机译:信号检测中的中药警戒性:基于决策树的数据分类

获取原文
           

摘要

Traditional Chinese Medicine (TCM) is a style of traditional medicine informed by modern medicine but built on a foundation of more than 2500?years of Chinese medical practice. According to statistics, TCM accounts for approximately 14% of total adverse drug reaction (ADR) spontaneous reporting data in China. Because of the complexity of the components in TCM formula, which makes it essentially different from Western medicine, it is critical to determine whether ADR reports of TCM should be analyzed independently. Reports in the Chinese spontaneous reporting database between 2010 and 2011 were selected. The dataset was processed and divided into the total sample (all data) and the subsample (including TCM data only). Four different ADR signal detection methods-PRR, ROR, MHRA and IC- currently widely used in China, were applied for signal detection on the two samples. By comparison of experimental results, three of them—PRR, MHRA and IC—were chosen to do the experiment. We designed several indicators for performance evaluation such as R (recall ratio), P (precision ratio), and D (discrepancy ratio) based on the reference database and then constructed a decision tree for data classification based on such indicators. For PRR: R1-R2?=?0.72%, P1-P2?=?0.16% and D?=?0.92%; For MHRA: R1-R2?=?0.97%, P1-P2?=?0.20% and D?=?1.18%; For IC: R1-R2?=?1.44%, P2-P1?=?4.06% and D?=?4.72%. The threshold of R,Pand Dis set as 2%, 2% and 3% respectively. Based on the decision tree, the results are “separation” for PRR, MHRA and IC. In order to improve the efficiency and accuracy of signal detection, we suggest that TCM data should be separated from the total sample when conducting analyses.
机译:中医(TCM)是一种以现代医学为基础的传统医学风格,但建立在2500多年的中医实践基础上。据统计,中药约占中国自发药品不良反应报告总数的14%。由于中药配方中各成分的复杂性,使其与西药有本质的区别,因此确定是否应独立分析中药的ADR报告至关重要。选择了自发报告数据库中2010年至2011年之间的报告。处理数据集并将其分为总样本(所有数据)和子样本(仅包括TCM数据)。目前在中国广泛使用的四种不同的ADR信号检测方法-PRR,ROR,MHRA和IC被用于两个样本的信号检测。通过比较实验结果,选择了其中的三个(PRR,MHRA和IC)进行实验。我们在参考数据库的基础上设计了R(召回率),P(精确率)和D(差异率)等绩效评估指标,然后基于这些指标构建了用于数据分类的决策树。对于PRR:R1-R2≥0.72%,P1-P2≥0.16%,D≥0.92%。对于MHRA:R1-R2≥0.97%,P1-P2≥0.20%,D≥1.18%。对于IC:R1-R2≥1.44%,P2-P1≥4.06%,D≥4.72%。 R,Pand Dis的阈值分别设置为2%,2%和3%。基于决策树,结果是PRR,MHRA和IC的“分离”。为了提高信号检测的效率和准确性,我们建议在进行分析时,应将中药数据与总样品分开。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号